210 related articles for article (PubMed ID: 20642852)
1. Malignant mixed Mullerian tumors of the uterus: histopathological evaluation of cell cycle and apoptotic regulatory proteins.
Kanthan R; Senger JL; Diudea D
World J Surg Oncol; 2010 Jul; 8():60. PubMed ID: 20642852
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of P16 and P53 expression in uterine malignant mixed mullerian tumors.
Buza N; Tavassoli FA
Int J Gynecol Pathol; 2009 Nov; 28(6):514-21. PubMed ID: 19851197
[TBL] [Abstract][Full Text] [Related]
3. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
Costa MJ; Guinee D
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
[TBL] [Abstract][Full Text] [Related]
4. Malignant mixed müllerian tumor of the uterus. Features favoring its origin from a common cell clone and an epithelial-to-mesenchymal transformation mechanism of histogenesis.
Guarino M; Giordano F; Pallotti F; Polizzotti G; Tricomi P; Cristofori E
Tumori; 1998; 84(3):391-7. PubMed ID: 9678624
[TBL] [Abstract][Full Text] [Related]
5. Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics.
Chen X; Arend R; Hamele-Bena D; Tergas AI; Hawver M; Tong GX; Wright TC; Wright JD
Int J Gynecol Pathol; 2017 Sep; 36(5):412-419. PubMed ID: 28700424
[TBL] [Abstract][Full Text] [Related]
6. Expression of cell cycle proteins in male breast carcinoma.
Kanthan R; Fried I; Rueckl T; Senger JL; Kanthan SC
World J Surg Oncol; 2010 Feb; 8():10. PubMed ID: 20152033
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of p53, p21/waf1, rb, p16, cyclin D1, p27, Ki67, cyclin A, cyclin B1, bcl2, bax and bak proteins and apoptotic index in normal thymus.
Kanavaros P; Stefanaki K; Rontogianni D; Papalazarou D; Sgantzos M; Arvanitis D; Vamvouka C; Gorgoulis V; Siatitsas I; Agnantis NJ; Bai M
Histol Histopathol; 2001 Oct; 16(4):1005-12. PubMed ID: 11642719
[TBL] [Abstract][Full Text] [Related]
8. Malignant mixed Müllerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 44 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Sullivan S; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):18-24. PubMed ID: 9454654
[TBL] [Abstract][Full Text] [Related]
9. Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus.
Clement PB; Zubovits JT; Young RH; Scully RE
Int J Gynecol Pathol; 1998 Jul; 17(3):211-22. PubMed ID: 9656116
[TBL] [Abstract][Full Text] [Related]
10. Malignant mixed müllerian tumor of the ovary: report of a case and review of the literature.
Shy SW; Lee WH; Lee MS; Lee MC
Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jun; 51(6):468-73. PubMed ID: 8281496
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
Mikami Y; Hata S; Kiyokawa T; Manabe T
Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
[TBL] [Abstract][Full Text] [Related]
12. Primary malignant mixed Müllerian tumor (metaplastic carcinoma) of the female peritoneum. A clinical, pathologic, and immunohistochemical study of three cases and a review of the literature.
Garamvoelgyi E; Guillou L; Gebhard S; Salmeron M; Seematter RJ; Hadji MH
Cancer; 1994 Aug; 74(3):854-63. PubMed ID: 7518735
[TBL] [Abstract][Full Text] [Related]
13. Loss of p16 in recurrent malignant mixed müllerian tumors of the uterus.
Robinson-Bennett B; Belch RZ; Han AC
Int J Gynecol Cancer; 2006; 16(3):1354-7. PubMed ID: 16803529
[TBL] [Abstract][Full Text] [Related]
14. Malignant mixed mullerian tumor in a rabbit (Oryctolagus cuniculus): case report with immunohistochemistry.
Goto M; Nomura Y; Une Y; Goldschmidt MH
Vet Pathol; 2006 Jul; 43(4):560-4. PubMed ID: 16847001
[TBL] [Abstract][Full Text] [Related]
15. Primary peritoneal malignant mixed mesodermal (Müllerian) tumor.
Hussein MR; Hussein SR; Abd-Elwahed AR
Tumori; 2009; 95(4):525-31. PubMed ID: 19856669
[TBL] [Abstract][Full Text] [Related]
16. Oncoprotein profiles of primary peritoneal malignant mixed müllerian tumors.
Ng JS; Han AC; Edelson MI; Rosenblum NG
Int J Gynecol Cancer; 2003; 13(6):870-4. PubMed ID: 14675326
[TBL] [Abstract][Full Text] [Related]
17. Determining predominating histologic component in malignant mixed müllerian tumors: is it worth it?
Ozguroglu M; Bilici A; Ilvan S; Turna H; Atalay B; Mandel N; Sahinler I
Int J Gynecol Cancer; 2008; 18(4):809-12. PubMed ID: 17892455
[TBL] [Abstract][Full Text] [Related]
18. Eight cases of malignant mixed Müllerian tumor (carcinosarcoma) of the uterus: findings in SurePath™ cervical cytology.
Gupta N; Dudding N; Smith JH
Diagn Cytopathol; 2014 Feb; 42(2):165-9. PubMed ID: 22865798
[TBL] [Abstract][Full Text] [Related]
19. Malignant mixed Müllerian tumors of the uterus. An immunohistochemical study.
Auerbach HE; LiVolsi VA; Merino MJ
Int J Gynecol Pathol; 1988; 7(2):123-30. PubMed ID: 3294195
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis.
Suzuki Y; Nakano T; Kato S; Ohno T; Tsujii H; Oka K
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):231-6. PubMed ID: 15337561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
